ArticleExpert review of precision medicine and drug development2021
Clinical application of personalized rheumatoid arthritis risk information: Translational epidemiology leading to precision medicine.
Jeffrey A SparksPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.